Trafalgar International GCAN
OTC GCAN
$0.35 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Trafalgar International (GCAN) Other Accumulated Expenses (2017 - 2026)

Trafalgar International (GCAN) posted Other Accumulated Expenses of $268600.0 for Q1 2026, up 1.9% on a QoQ basis from $263600.0 in Q4 2025, and up 3.31% year-over-year from $260000.0 in Q1 2025.

Analysis

Trafalgar International (GCAN) Other Accumulated Expenses (2017 - 2026) Analysis & Trends

Trafalgar International has reported Other Accumulated Expenses for 9 years, with the latest figure at $268600.0 in Q1 2026.

  • On a quarterly basis, Other Accumulated Expenses rose 3.31% year-over-year to $268600.0 in Q1 2026; TTM through Mar 2026 was $268600.0, a 3.31% increase from a year earlier, with the FY2025 full-year figure at $263600.0, up 1.38% from the prior year.
  • Other Accumulated Expenses was $268600.0 for Q1 2026 at Trafalgar International, up from $263600.0 in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $268600.0 in Q1 2026, with the low at $260000.0 in Q4 2022.
  • Average Other Accumulated Expenses over 5 years is $260871.4, with a median of $260000.0 recorded in 2022.
  • The sharpest annual moves came in 2023 and 2026: Other Accumulated Expenses changed 0.0% in 2023, then advanced 3.31% in 2026.
  • Over 5 years, Other Accumulated Expenses stood at $260000.0 in 2022, then changed by 0.0% to $260000.0 in 2023, then changed by 0.0% to $260000.0 in 2024, then grew by 1.38% to $263600.0 in 2025, then advanced by 1.9% to $268600.0 in 2026.
  • The last three Other Accumulated Expenses figures came in at $268600.0 (Q1 2026), $263600.0 (Q4 2025), and $260000.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn
7 Revolution Medicines 45.00 Bn 45.00 Bn -
8 Incyte 25.47 Bn 20.94 Bn 1.57 Bn
9 United Therapeutics 20.81 Bn 18.15 Bn 683.80 Mn
10 Trafalgar International 217,335.05 217,335.05 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 268,600.00
Dec 31, 2025 263,600.00
Sep 30, 2025 260,000.00
Jun 30, 2025 260,000.00
Mar 31, 2025 260,000.00
Dec 31, 2024 260,000.00
Sep 30, 2024 260,000.00
Jun 30, 2024 260,000.00
Mar 31, 2024 260,000.00
Dec 31, 2023 260,000.00
Sep 30, 2023 260,000.00
Jun 30, 2023 260,000.00
Mar 31, 2023 260,000.00
Dec 31, 2022 260,000.00
Jun 30, 2020 50,000.00
Mar 31, 2020 50,000.00
Dec 31, 2019 50,000.00
Mar 31, 2018 91,305.00
Dec 31, 2017 87,397.00